The DOI matches its Crossref record.
Receptor-Mediated Intrarenal Angiotensin II Augmentation in Angiotensin II–Infused Rats
Abstract
Chronic low-dose angiotensin II (Ang II) infusion for 13 days mimics two-kidney, one clip Goldblatt hypertension and increases intrarenal Ang II levels. We performed studies to determine the time course for the enhancement of intrarenal Ang II levels and whether the increased intrarenal Ang II is a tissue-specific event and requires a receptor-mediated step. Male Sprague-Dawley rats were uninephrectomized, and either vehicle or Ang II (40 ng/min) was infused via a subcutaneous osmotic minipump. Plasma and renal Ang II levels were measured 3, 7, 10, and 13 days after minipump implantation. Compared with controls (126±2 mm Hg), systolic pressure in Ang II–infused rats exhibited a detectable increase by day 6 (146±2 mm Hg) and continued to increase to 189±5 mm Hg by day 12. Plasma Ang II levels were elevated by day 3, whereas intrarenal Ang II levels were not significantly elevated until 10 days of Ang II infusion. Renal injury characterized by focal and segmental glomerulosclerosis was evident after 13 days of Ang II infusion. Losartan (30 mg/kg per day) prevented the development of hypertension in the Ang II–infused rats for the duration of the infusion period (125±1 mm Hg) and reduced the degree of glomerular injury. Plasma renin activity was suppressed in the Ang II–infused group but was elevated markedly in both losartan-treated groups. Plasma Ang II levels were elevated in the Ang II–infused rats and were even higher during losartan treatment. Intrarenal Ang II levels were enhanced significantly (354±60 versus 164±23 fmol/g) in the Ang II–infused rats. However, losartan treatment prevented the augmentation of intrarenal Ang II caused by Ang II infusion. Heart and adrenal Ang II levels were not significantly increased in the Ang II–infused rats but were significantly elevated during losartan treatment. These results suggest that the tissue-specific elevations of intrarenal Ang II levels caused by chronic Ang II infusion are mediated by angiotensin type 1 receptor activation, which leads to either receptor-mediated internalization of Ang II, enhancement of intrarenal Ang II formation, or both.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Self-citationAngiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Regulation of Intrarenal Angiotensin II in Hypertension
Navar, L. G., Harrison-Bernard, L. M., Nishiyama, A., & Kobori, H. (2002) · Hypertension · doi:10.1161/hy0202.103821 · Cited by 375
Self-citationRenovascular Hypertension and Ischemic Nephropathy
Garovic, V. D., & Textor, S. C. (2005) · Circulation · doi:10.1161/circulationaha.104.492348 · Cited by 296
Regulation of renin: new evidence from cultured cells and genetically modified mice
Bader, M., & Ganten, D. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000089 · Cited by 80
Liu, D., Gao, L., Roy, S. K., Cornish, K. G., & Zucker, I. H. (2006) · Circulation Research · doi:10.1161/01.res.0000247066.19878.93 · Cited by 67
Metadata
- Authors
- Zou, L.-X., Imig, J. D., Von Thun, A. M., Hymel, A., Ono, H., & Navar, L. G.
- Venue
- Hypertension
- Published
- 1996-10
- Volume
- 28
- Issue
- 4
- Pages
- 669-677
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2163224216
- Cited by
- 192
- References
- 0
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.